HEPA: SEC Form 4 filed by Hepion Pharmaceuticals Inc.
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for HEPA
Earlier insider filings at HEPA
- Oct 2, 2026Director Fisher Danina bought $10,000 worth of shares (200,000 units at $0.05) (SEC Form 4)
- Sep 14, 2026SEC Form 4 filed by Executive Chairman Lopriore Vincent S
- Sep 10, 2026SEC Form 4 filed by Director Purcell Michael J.
- Aug 21, 2026SEC Form 4 filed by Interim CEO Stetz Gary S.
- Aug 21, 2026SEC Form 4 filed by Executive Chairman Lopriore Vincent S
Quantisnow market dataNASDAQ
HEPA
Hepion Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for HEPA
Full HEPA profile on Quantisnow Follow HEPA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time